Virtus Investment Advisers, Inc. has filed its 13F form on August 14, 2024 for Q2 2024 where it was disclosed a total value porftolio of $112 Million distributed in 335 stocks.
Among their holdings, we can observe that their the top five positions include companies like: Nvidia Corp with a value of $3.87M, Icici Bank LTD with a value of $3.62M, Virtus ETF Tr Ii Virtus Duff & with a value of $2.55M, Microsoft Corp with a value of $2.47M, and Apple Inc. with a value of $2.11M.
Examining the 13F form we can see an decrease of $21M in the current position value, from $133M to 112M .
Virtus Investment Advisers, Inc. is based out at Hartford, CT
Below you can find more details about Virtus Investment Advisers, Inc. portfolio as well as his latest detailed transactions.
Portfolio value
$112 Million
Technology: $22.5 Million
Healthcare: $18.5 Million
Industrials: $18 Million
Financial Services: $15.6 Million
Consumer Cyclical: $15 Million
Consumer Defensive: $6.82 Million
Utilities: $3.81 Million
Basic Materials: $3.7 Million
Other: $7.75 Million
Stock
Market Cap.
Holding Value (Reported)
# of Shares.
Last Trade
Trade History
-
$0
0.0% of portfolio
-
Q4 2023
New
-
$0
0.0% of portfolio
-
Q2 2024
New
-
$0
0.0% of portfolio
-
Q4 2023
New
-
$0
0.0% of portfolio
-
Q4 2023
New
-
$0
0.0% of portfolio
-
Q4 2023
New
-
$0
0.0% of portfolio
-
Q4 2023
New
-
$0
0.0% of portfolio
-
Q4 2023
New
-
$0
0.0% of portfolio
-
Q1 2024
New
-
$0
0.0% of portfolio
-
Q2 2024
New
-
$0
0.0% of portfolio
-
Q2 2024
New
-
$0
0.0% of portfolio
-
Q1 2024
New
-
$0
0.0% of portfolio
-
Q1 2024
Added 14.29%
Halozyme Therapeutics Inc
-
$0
0.0% of portfolio
-
Q1 2024
New
-
$0
0.0% of portfolio
-
Q4 2023
New
-
$0
0.0% of portfolio
-
Q4 2023
New
-
$0
0.0% of portfolio
-
Q4 2023
New
-
$0
0.0% of portfolio
-
Q1 2024
New
-
$0
0.0% of portfolio
-
Q1 2024
New
-
$0
0.0% of portfolio
-
Q2 2024
Added 40.0%
-
$0
0.0% of portfolio
-
Q4 2023
New
-
$0
0.0% of portfolio
-
Q2 2024
Added 38.1%
American Airlines Group Inc
-
$0
0.0% of portfolio
-
Q1 2024
New
-
$0
0.0% of portfolio
-
Q4 2023
New
-
$0
0.0% of portfolio
-
Q4 2023
New
Alnylam Pharmaceuticals Inc
-
$0
0.0% of portfolio
-
Q4 2023
New
Zeekr Intelligent Technology
-
$0
0.0% of portfolio
-
Q2 2024
New
-
$0
0.0% of portfolio
-
Q4 2023
New
-
$0
0.0% of portfolio
-
Q4 2023
New
-
$0
0.0% of portfolio
-
Q4 2023
New
-
$0
0.0% of portfolio
-
Q4 2023
New
-
$0
0.0% of portfolio
-
Q4 2023
New
Collegium Pharmaceutical Inc
-
$0
0.0% of portfolio
-
Q1 2024
New
-
$0
0.0% of portfolio
-
Q2 2024
New
-
$0
0.0% of portfolio
-
Q4 2023
New
-
$0
0.0% of portfolio
-
Q1 2024
Added 13.89%
-
$0
0.0% of portfolio
-
Q4 2023
New
-
$0
0.0% of portfolio
-
Q4 2023
New
-
$0
0.0% of portfolio
-
Q4 2023
New
-
$0
0.0% of portfolio
-
Q4 2023
New
-
$0
0.0% of portfolio
-
Q2 2024
Reduced 69.84%
-
$0
0.0% of portfolio
-
Q3 2023
New
-
$0
0.0% of portfolio
-
Q2 2024
New
-
$0
0.0% of portfolio
-
Q2 2024
New
-
$0
0.0% of portfolio
-
Q4 2023
New
-
$0
0.0% of portfolio
-
Q2 2024
Added 46.0%
-
$0
0.0% of portfolio
-
Q1 2024
New
-
$0
0.0% of portfolio
-
Q4 2023
New
-
$0
0.0% of portfolio
-
Q4 2023
New
-
$0
0.0% of portfolio
-
Q4 2023
New
-
$0
0.0% of portfolio
-
Q2 2024
New